Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma

被引:0
作者
Yaping Xu
Fei Fang
Hui Jiao
Xiaohui Zheng
Liyue Huang
Xue Yi
Wenxiu Zhao
机构
[1] Xiamen Medical College,Key Laboratory of Functional and Clinical Translational Medicine, Department of Physiology
[2] Xiamen University,Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital
[3] Xiamen Key Laboratory of Respiratory Diseases,undefined
来源
Cancer Immunology, Immunotherapy | 2019年 / 68卷
关键词
Hepatic stellate cells; Myeloid-derived suppressor cells; Hepatocellular carcinoma; SDF-1; CXCR4; Migration;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatic stellate cells (HSCs) are important stromal cells and pivotal mediators involved in the pathogenesis and immunosuppression of hepatocellular carcinoma (HCC). The liver has been demonstrated to be a site for accumulation of tumor-induced myeloid-derived suppressor cells (MDSCs). We previously reported that HSCs induced an increase in the number of MDSCs in HCC. However, how MDSCs are recruited in HCC remains largely unclear. In the present study, we found that HSC-conditioned medium (HSC-CM) induced bone marrow-derived cell and splenocyte migration, especially MDSC migration. Using chemokine-neutralizing antibodies and chemokine receptor inhibitors, we found that HSCs promoted MDSC migration through the SDF-1/CXCR4 axis. Subsequently, we used an orthotopic mouse liver tumor model to determine how HSCs mediated MDSC migration to HCC in vivo. The in vivo results indicated that pretreatment of MDSCs with a CXCR4 inhibitor or injection with SDF-1-knocked down HSCs inhibited MDSC migration to the spleen and liver of the tumor-bearing mice. Together, our findings indicate a central role for HSCs in MDSC migration mediated by the SDF-1/CXCR4 axis, thus revealing a potentially effective approach for modulating the tumor microenvironment by targeting HSCs in HCC.
引用
收藏
页码:1959 / 1969
页数:10
相关论文
共 369 条
  • [1] Zhang H(2017)Critical role of myeloid-derived suppressor cells in tumor-induced liver immune suppression through inhibition of NKT cell function Front Immunol 8 129-807
  • [2] Li Z(2009)Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor Hepatology 50 799-174
  • [3] Wang L(2009)Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 162-77
  • [4] Tian G(2012)Myeloid cells in tumor inflammation Vasc Cell 4 14-35
  • [5] Tian J(2010)Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine Can Res 70 68-6975
  • [6] Yang Z(2008)Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis Cancer Cell 13 23-503
  • [7] Cao G(2011)Combined blockade of integrin-alpha4beta1 plus cytokines SDF-1alpha or IL-1beta potently inhibits tumor inflammation and growth Cancer Res 71 6965-220
  • [8] Zhou H(2012)Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance Cancer Cell 21 488-5521
  • [9] Zhao L(2008)HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion Cancer Cell 13 206-1013
  • [10] Wu Z(2009)The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression Cancer Res 69 5514-177